Home
About us
Pathologies
- Mitral valve regurgitation
- Urinary incontinence
Our activities
- Kalios™
- Epygon
- Artus
- Kardiozis
Join us
News
Investors

Return to the news page

biotechinfo

Carvolix relies on three technologies: Epygon, Kalios and Artus

March 27, 2023

Interview with Sébastien Ladet, CEO of Carvolix

See the article

Contact

Carvolix SA
320 avenue Archimède
Les pléiades III Batiment B
13100 AIX-EN-PROVENCE
contact@carvolix.eu
+33 4 42 95 12 20

Public relations France

PRIMATICE
Thomas Roborel de Climens
thomasdeclimens@dgm-conseil.fr
+33 6 78 12 97 95

Investors

SEITOSEI.ACTIFIN
Ghislaine Gasparetto
ghislaine.gasparetto@seitosei-actifin.com
+33 6 85 36 76 81

Copyright 2026 Affluent Medical – All rights reserved – Legal Information

Contact

Carvolix SA
320 avenue Archimède
Les pléiades III Batiment B
13100 AIX-EN-PROVENCE
contact@carvolix.eu
+33 4 42 95 12 20

Relations presse France

PRIMATICE
Thomas Roborel de Climens
thomasdeclimens@dgm-conseil.fr
+33 6 78 12 97 95

Investisseurs

ACTIFIN
Ghislaine Gasparetto
ggasparetto@actifin.fr
+33 6 21 10 49 24

Copyright 2026 Affluent Medical – Tous les droits sont réservés – Information légale